Trump Overrules D.C. Swamp, Will Sign New ‘Favored Nation’ Order

President Donald Trump has overruled the Washington, D.C., swamp and said he will sign a new "favored nations" order.

The White House is currently writing an executive order that would reduce what the U.S. pays for drugs so that it's more in line with the lowest price paid elsewhere in the world.


Under this system, patients in the U.S. would pay no more than the country with the lowest prescription drug prices.

If a certain medicine is cheaper in another country, the U.S. would be required to match that price under this order.

Trump referenced the executive order on Friday while speaking with reporters.

"As you know, for years and years other nations paid less for drugs than we do," Trump said Friday at the White House.

"Sometimes by 60-70%. We’re working on it right now, we’re working on a favored nations clause, where we pay whatever the lowest nation’s price is. Why should other nations — like Canada — but why should other nations pay much less than us? They’ve taken advantage of the system for a long time, Pharma," he added.

Here's more from the Washington Examiner:

Trump said the announcement was coming "very shortly" but did not provide other details about how the plan would work. A "favored nations clause" refers to a contract in which a seller gives buyers the same best terms that it offers to other buyers.
Last year, the Department of Health and Human Services proposed an "international drug pricing index" that would help Medicare pay similar rates for drugs as what other countries do.
The president has been eager to deliver on his campaign promise to lower drug prices in the U.S., and has decried what he calls a "global freeloading" system in which drug companies are able to offer their products at a lower cost to other countries by charging the U.S. more.
Trump vowed when he was running for president that he would go after pharmaceutical companies, whom he said "are getting away with murder," and floated the idea of giving the government more control in Medicare to directly negotiate prices.
The Trump administration has passed a rule requiring drug companies to post their list prices in commercials, and is weighing a rule that would let Medicare negotiate the prices of drugs that are administered in doctors' offices. His administration is also supporting letting states set up arrangements to import drugs from Canada.

Congress and lawmakers have claimed for years that they are both trying to bring more transparency to drug prices and, ultimately, lower costs for consumers.

But the Trump administration if stepping up and this new executive order should drive down the cost of pharmaceutical drugs for many Americans.